Skip to Content

Join the 'Talimogene Laherparepvec' group to help and get support from people like you.

Talimogene Laherparepvec News

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, ...

U.S. Pays Highest Prices for Cancer Meds: Study

Posted 6 Jun 2016 by

MONDAY, June 6, 2016 – The United States pays the highest prices in the world for generic and brand-name cancer drugs, a new study has found. However, as the world's wealthiest nation, the United States is better able to pay for those pricey drugs than poorer countries with somewhat lower medication prices, added study lead author Dr. Daniel Goldstein. People in China and India are much less ...

'Precision' Cancer Treatment May Extend Lives

Posted 20 May 2016 by

THURSDAY, May 19, 2016 – "Precision" cancer treatment that's guided by genetic clues from the patient's own tumor appears to outperform traditional chemotherapy, a new research review finds. Patients given precision – or personalized – treatment experienced a tumor shrinkage rate six times that attained by regular chemotherapy. But, that only happened if doctors used genetic information to ...

Injected Drug Approved for Melanoma Skin Cancer

Posted 4 Nov 2015 by

WEDNESDAY, Oct. 28, 2015 – Imlygic (talimogene laherparepvec) has been approved by the U.S. Food and Drug Administration to treat melanoma of the skin and lymph nodes. Melanoma is the leading cause of death from skin cancer, affecting some 74,000 additional Americans annually and killing about 10,000, the FDA said in a news release. Imlygic, made from a genetically modified herpes virus, is ...

New Treatment for Melanoma Gets FDA Approval

Posted 4 Nov 2015 by

WEDNESDAY, Oct. 28, 2015 – A genetically engineered cold sore virus that "blows up" melanoma tumors has been approved by the U.S. Food and Drug Administration to help treat the deadly skin cancer. Imlygic (talimogene laherparepvec), a first-of-its-kind therapy, showed promise against lesions in the skin and lymph nodes in an early trial, the FDA said Tuesday. However, the therapy did not improve ...

FDA Approves Imlygic (talimogene laherparepvec) for the Treatment of Melanoma

Posted 28 Oct 2015 by

October 27, 2015 – The U.S. Food and Drug Administration today approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the skin and lymph nodes. “Melanoma is a serious disease that can advance and spread to other parts of the body, where it becomes difficult to treat,” said Karen Midthun, M.D., director of the FDA’s Ce ...

Ask a Question

Further Information

Related Condition Support Groups

Melanoma, Melanoma - Metastatic

Related Drug Support Groups


Talimogene Laherparepvec Patient Information at